NCT04507191View on ClinicalTrials.gov

PDL1 in Ovarian High Grade Serous Carcinoma

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

December 1, 2012

Primary Completion Date

December 1, 2019

Study Completion Date

December 30, 2019

Conditions
Ovarian Cancer
Interventions
DIAGNOSTIC_TEST

immunohistochemical staining

immunohistochemical staining of programmed death-ligand 1 (PDL1) marker

Trial Locations (1)

42511

Faculty of Medicine, Port Said University, Port Said

All Listed Sponsors
collaborator

Mansoura University Hospital

OTHER

lead

Port Said University hospital

OTHER

NCT04507191 - PDL1 in Ovarian High Grade Serous Carcinoma | Biotech Hunter | Biotech Hunter